Terumo (OTCMKTS:TRUMY) Sees Unusually-High Trading Volume – Here’s What Happened

Terumo Corp. (OTCMKTS:TRUMY) saw an uptick in trading volume on Wednesday . 670,774 shares traded hands during trading, an increase of 74% from the previous session’s volume of 386,321 shares.The stock last traded at $13.65 and had previously closed at $13.59.

Terumo Stock Up 0.1%

The business’s 50 day simple moving average is $14.22 and its 200-day simple moving average is $15.96. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.46 and a current ratio of 2.51. The company has a market cap of $20.06 billion, a price-to-earnings ratio of 22.67 and a beta of 0.74.

Terumo (OTCMKTS:TRUMY) last issued its earnings results on Wednesday, November 12th. The company reported $0.16 EPS for the quarter, meeting analysts’ consensus estimates of $0.16. Terumo had a return on equity of 9.39% and a net margin of 12.35%.The firm had revenue of $1.86 billion for the quarter, compared to the consensus estimate of $1.75 billion.

About Terumo

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.